antiviral drug

Britain’s health ministry announced Tuesday that it will expand access to Pfizer’s PFE.N oral antiviral COVID-19 therapy to thousands more individuals by enrolling them in a trial evaluating the drug’s optimal usage in its highly vaccinated population. People with weakened immune systems in the United Kingdom can now use Paxlovid, which combines Pfizer’s new tablet … Read more